About US
Contact us
-
Bigger Capacity Benchtop Autoclave Meets Customer Wish ListThe Priorclave H60 compact autoclave, designed specifically to meet a customer requirement for a steam steriliser with all the proven strengths and features of the current Priorclave Compact range but2014/10/13
-
Nabriva’s lefamulin receives FDA fast-track status to treat CABP and ABSSSIAustria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for its lefamulin (BC 3781). The2014/10/11
-
The top 10 biggest pharmaceutical companies of 2014Five of the world’s ten biggest pharmaceutical companies are based in the US, while the remaining five hail from Switzerland, the UK and France. Pharmaceutical-technology.com profiles the world’s ten2014/10/11
-
Cipla Medpro to market Teva’s pharmaceutical products in South AfricaCipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva Pharmaceuticals. As part of the deal, Medpro will exclusively market Teva's pharmaceutical product portfolio in So2014/10/10
-
Pfizer introduces new medicines optimisation scratch cardUS-based Pfizer has introduced a new scratch card in a bid to involve the public in medicines optimisation. The card has been designed to increase patient engagement with the pharmacy team and create2014/10/10
-
Cipla and S&D Pharma partner for business in Czech Republic and SlovakiaIndia-based Cipla has partnered with UK's S&D Pharma to launch affordable, high-quality alternatives in the Czech Republic and Slovakia. Under the deal, Cipla will introduce its respiratory produ2014/10/9
-
Merck to buy Sigma-Aldrich for $17bnUS-based Merck has signed an agreement to acquire Sigma-Aldrich for $17bn (€13.1bn), which will boost the company's position in the life science industry.Under the deal, Merck will acquire all outstan2014/10/9
-
AbbVie’s Humira receives FDA approval to treat Crohn’s disease in paediatric patientsAbbVie has received approval from the US Food and Drug Administration (FDA) for its Humira (adalimumab) to treat paediatric patients with moderately to severely active Crohn's disease. The drug has b2014/10/8
-
Patheon to Showcase its Complex Formulation Technologies Expertise at CPhI/ICSE - Japan ConferencePatheon personnel and scientific experts will be available to meet at the CPhI/ICSE - Japan conference in Tokyo from 9-11 April to discuss how Patheon can actively support pharmaceutical and biotech c2014/10/8
-
Patheon® to Feature API Development and Manufacturing Capabilities at CPhI/ICSE WorldwidePatheon is to showcase its biologic, small molecule API development services and manufacturing capabilities for finished dosage forms at CPhI / ICSE Worldwide from Tuesday 7 October to Thursday 9 Octo2014/10/8